Search

Your search keyword '"Quaini F"' showing total 359 results

Search Constraints

Start Over You searched for: Author "Quaini F" Remove constraint Author: "Quaini F"
359 results on '"Quaini F"'

Search Results

2. Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML

4. PO-2243 Development of a µCT radiomic platform to identify radio-immune signatures in murine tumor models

5. 238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors

6. 1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC

7. P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer

11. 165P Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens

12. Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia

13. 17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients

14. P57.08 High Performance Radiomic Classifier to Predict the Response to Immunotherapy in Advanced NSCLC

15. 1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy

24. Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients

25. 1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients

26. Genetic, tissue and circulating PD-L1 profiling to predict the response to immuno-checkpoint inhibitors in advanced NSCLC

27. Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?

32. Differentially regulated high-throughput CT imaging features correlate to distinct tumor immune contextures portraying a radiomic signature with prognostic impact on surgically resected NSCLC

33. Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC

37. Diabetes induces systemic microvascular remodelling

39. Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC

42. Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab

45. Effects of the injection of pharmacologically active microcarriers releasing HGF/IGF-1 and transporting adipose-derived stem cells in the infarcted heart

47. Pharmacologically active microcarriers conveying human adipose-derived stem cells and/or releasing growth factors in myocardial regeneration

48. Functional recovery of the infarcted heart mediated by pharmacologically active microcarriers conveying human adipose-derived stem cells and/or releasing growth factors

Catalog

Books, media, physical & digital resources